Celebrating Five Decades of Innovation and Excellence
In 1974, the vision of the newly formed Fox Chase Cancer Center was to weave cancer research, treatment, and prevention together to develop a synthesis that would lead to more effective treatment and ensure that patients received the best care possible.
If the previous 50 years are any indication, additional decades of innovation in cancer discovery and delivery await Fox Chase.
50 Years of Fox Chase Cancer Center
Explore our milestones and achievements over the last five decades
LEADERSHIP LETTER
A Golden Anniversary Celebrates a Golden History
To be golden alludes to a level of excellence. It conveys the attainment of success. It can even describe a sense of purity in one’s approach … of staying true to oneself.
This year, as we mark the golden anniversary of Fox Chase Cancer Center, we celebrate 50 years of excellence in cancer research and care. We also express immeasurable gratitude for the many people who have contributed to our culture of compassion and our mission of discovery and delivery from our formation in 1974 to this milestone year of 2024.
To commemorate this occasion, we present this special issue of Forward. In its pages, we invite you to join us on a journey, one that brings together archival and contemporary photography, the written word, and tasteful graphics that invite us to reflect while at the same time evoking a sense of pride, belonging, and aspiration.
Organized into three sections — Past, Present, and Future — the text and photos highlight the rich legacy of our institution and its longtime standing as a National Cancer Institute-designated Comprehensive Cancer Center, communicates our strategic goals as we focus on our current place in the cancer community, and envisions the future of cancer care with insights from our own faculty.
The Past section covers the years 1974 through 2024 and features notable research accomplishments, important clinical advances, and key figures in Fox Chase’s history.
The Present section focuses on 2024 through 2028 — the years outlined in our new strategic plan — with details on our work as it relates to Discovery, Delivery, Community, Development, Culture, Growth, and Infrastructure.
The Future section addresses the next decade, 2024 through 2034, with researchers from our laboratories and clinics weighing in on where their fields of study are going in general and the direction of their own research specifically.
Considered in their totality, these three sections demonstrate that the magnitude of Fox Chase Cancer Center’s impact transcends any one person and that the boldness of our mission reflects our enduring quest to dream and to dare. They also underscore how throughout our 50 years, we have maintained an ever-present sense of empathy and dignity, exemplifying the goodness of humanity by staying true to who we are. That is, thinking of our patients above all else. It is for them that we are here, doing what we do, and it is for them that we will continue for years to come.
LEADERSHIP LETTER
A Golden Anniversary Celebrates a Golden History
To be golden alludes to a level of excellence. It conveys the attainment of success. It can even describe a sense of purity in one’s approach … of staying true to oneself.
This year, as we mark the golden anniversary of Fox Chase Cancer Center, we celebrate 50 years of excellence in cancer research and care. We also express immeasurable gratitude for the many people who have contributed to our culture of compassion and our mission of discovery and delivery from our formation in 1974 to this milestone year of 2024.
To commemorate this occasion, we present this special issue of Forward. In its pages, we invite you to join us on a journey, one that brings together archival and contemporary photography, the written word, and tasteful graphics that invite us to reflect while at the same time evoking a sense of pride, belonging, and aspiration.
Organized into three sections — Past, Present, and Future — the text and photos highlight the rich legacy of our institution and its longtime standing as a National Cancer Institute-designated Comprehensive Cancer Center, communicates our strategic goals as we focus on our current place in the cancer community, and envisions the future of cancer care with insights from our own faculty.
The Past section covers the years 1974 through 2024 and features notable research accomplishments, important clinical advances, and key figures in Fox Chase’s history.
The Present section focuses on 2024 through 2028 — the years outlined in our new strategic plan — with details on our work as it relates to Discovery, Delivery, Community, Development, Culture, Growth, and Infrastructure.
The Future section addresses the next decade, 2024 through 2034, with researchers from our laboratories and clinics weighing in on where their fields of study are going in general and the direction of their own research specifically.
Considered in their totality, these three sections demonstrate that the magnitude of Fox Chase Cancer Center’s impact transcends any one person and that the boldness of our mission reflects our enduring quest to dream and to dare. They also underscore how throughout our 50 years, we have maintained an ever-present sense of empathy and dignity, exemplifying the goodness of humanity by staying true to who we are. That is, thinking of our patients above all else. It is for them that we are here, doing what we do, and it is for them that we will continue for years to come.
World-Changing Past. Vibrant Present. Limitless Future.
Weaving Together Cancer Research, Prevention, and Treatment
Through key clinical trials and translational research, Fox Chase has played a critical role in the development of therapeutics and treatment approaches.
A Four-Year Plan for the Future of Fox Chase Cancer Center
In its mission to prevail over cancer, Fox Chase has developed specific goals to help usher in a new era of cancer innovation.
The Coming Decade of Potential Cancer Breakthroughs
Read how Fox Chase innovators are shaping the future of clinical medicine, basic research, and cancer prevention and control.
Expanding Access to Fox Chase Cancer Center’s High-Quality Care
Fox Chase has always sought to offer the best care available. Starting in the late 1990s, Fox Chase started working to make that care as convenient as possible as well. In 1996, Fox Chase - Huntingdon Pike opened its doors. A total of 10 new regional campuses or affiliates have opened, the most recent in 2024 in Voorhees, New Jersey. Roughly 20% of Fox Chase’s patients come from the Garden State, so that new location, like the others before it, offers the highest-quality care closer to home.
1. Fox Chase Cancer Center – Main Campus
Opened: 1974
Location: Philadelphia
Services Offered: All cancer care.
2. Fox Chase Cancer Center – Huntingdon Pike
Opened: 1996
Location: Rockledge, PA
Services Offered: Surgical urology consultations and benign urology procedures, intravesicular infusions, plastic and reconstructive surgery and dermatology consultations, Mohs surgery, minor procedures.
3. Fox Chase Cancer Center – Buckingham
Opened: 2009
Location: Furlong, PA
Services Offered: Radiation oncology clinic visits and radiation treatment, CyberKnife, diagnostic CT scans, general surgical, urology survivor consultations, genetic counseling, hematology/oncology consultations, infusion treatment.
4. Fox Chase Cancer Center – Temple University Hospital
Opened: 2012
Location: Philadelphia
Services Offered: Cutting-edge diagnosis, treatment, and management of all types of cancer, as well as access to clinical trials.
5. Fox Chase Cancer Center at Temple University Hospital – Northeastern Campus
Opened: 2015
Location: Philadelphia
Services Offered: Infusion treatment.
6. St. Lukes Cancer Center – Anderson
Opened: 2016
Location: Easton, PA
Services Offered: Consultations with physicians from the Fox Chase – Temple University Hospital Bone Marrow Transplant Program.
7. Fox Chase Cancer Center – East Norriton
Opened: 2017
Location: East Norriton, PA
Services Offered: Radiation oncology consultations and treatment; surgical consultations for breast, skin, sarcoma, GI, urologic oncology, benign urology, and plastic surgery; urology and breast survivor consultation; genetic counseling; hematology/oncology consultations; infusion treatment.
8. Fox Chase Cancer Center – Fort Washington
Opened: 2022
Location: Fort Washington, PA
Services Offered: Benign urology consultations and procedures.
9. Fox Chase Cancer Center – Chestnut Hill Hospital
Opened: 2024
Location: Philadelphia
Services Offered: Hematology/oncology and surgical consultations, infusion treatment, benign urology consultations and procedures.
10. Fox Chase Cancer Center – Voorhees
Opened: 2024
Location: Voorhees, NJ
Services Offered: Urologic oncology, benign urology, radiation oncology, plastic and reconstructive surgery consultations.
Patrick McGee Editor
Marian Auriemma Staff Writer
Sarah Hughes Editorial Coordinator
B&G Design Studios Design
Brilliant Graphics Printing
Inquiries editor@fccc.edu
LEADERSHIP
Jonathan Chernoff Cancer Center Director
Robert Uzzo President and CEO of Fox Chase Cancer Center
Joel Helmke Chief Operating Officer
Stefanie Murphy Senior Vice President and Chief Marketing Officer, Temple Health
Robin Priggemeier Associate VP, Marketing
Bryan Robinson Senior Vice President, External Relations, Temple Health
Jeremy Moore Associate VP, Communications
Patrick McGee Publications Manager
Inquiries: editor@fccc.edu
Editorial Advisory Board
Andrew Becker Director of Donor Relations; George Beschen Senior Director of Individual Giving; Margie L. Clapper, PhD Cancer Prevention & Control; Martin J. Edelman, MD Hematology/Oncology; Erica A. Golemis, PhD Deputy Chief Science Officer; Joel Helmke, MSHP, FACHE Chief Operating Officer; Bryan Robinson Senior Vice President, External Relations, Temple Health; Joshua E. Meyer, MD Radiation Oncology; Andrea S. Porpiglia, MD, MSc Surgical Oncology; Amanda Purdy, PhD Director, Academic Affairs; Camille Ragin, PhD, MPH Associate Director, Diversity, Equity, and Inclusion; Glenn F. Rall, PhD Chief Academic Officer; Jennifer Barsky Reese, PhD Cancer Prevention and Control Anna Liza Rodriguez, MSN, MHA, RN, OCN, NEA-BC Chief Nursing Officer; Rosalia Viterbo, MD Urology; David Wiest, PhD Scientific Director of the Research Institute of Fox Chase Cancer Center
Board of Directors
Joseph W. Marshall III, Chair; Christopher W. McNichol, Vice Chair; William J. Federici; Edward A. Glickman; Amy J. Goldberg, MD; Lewis F. Gould Jr.; Sandra Harmon-Weiss, MD; Thomas W. Hofmann; Solomon C. Luo, MD; David G. Marshall; Donald E. Morel Jr., PhD; Leon O. Moulder Jr.; Tina M. Pidgeon; Carl A. Sottosanti; Elaine Ward Sykes; Michael A. Young
Foundation Board of Directors
Donald E. Morel Jr., PhD, Chair; Louis E. Della Penna Sr., Vice Chair; Jonathan Chernoff, MD, PhD; Elaine Daniels; William J. Federici; Edward A. Glickman; Lewis F. Gould Jr.; Thomas W. Hofmann; Barbara Ilsen; Peter Kreindler; Philip E. Lippincott; Solomon C. Luo, MD; David G. Marshall; Barbara O’Donnell; Anna Marie Ahn Petersen; Tina Pidgeon; Kenneth Shropshire; Michael Smolenski;Thomas R. Tritton, PhD; Robert Uzzo, MD, MBA
Special thanks to our many contributors for this issue: Andrew S. Becker, George Beschen, Martin J. Edelman, Allison Goldstein, Jill Horne, Joe Hurley, Beth Lewis, Ilima Loomis, Thomas Stephano, Melissa Schrier
Forward magazine is published twice a year for friends of Fox Chase Cancer Center by the communications department of Fox Chase. One of the leading cancer research and treatment centers in the United States, Fox Chase was founded in 1904 as one of the nation’s first cancer hospitals, and was among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase joined Temple University Health System in 2012.
Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by The Lewis Katz School Temple University School of Medicine. TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.
Built with Shorthand